Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice

Luciano Rossetti, Nir Barzilai, Wei Chen, Thomas Harris, Deyun Yang, Charles E. Regler

Research output: Contribution to journalArticle

41 Scopus citations


The physiological role of circulating insulin-like growth factor-II (IGF- II) in adult humans is poorly understood. We recently generated an IGF-II transgenic murine model of persistent IGF-II production (plasma IGF-II ~30- fold increased above normal) through overexpression of the transgene driven by the major urinary protein promoter (Rinderknecht, E, and Humbel, R. E. (1978) J. Biol. Chem. 269, 13779-13784). To determine whether in vivo insulin action is improved in these transgenic mice, we performed euglycemic insulin (18 milliunits/kg · min) clamp studies in conscious IGF-II transgenic and in age- and weight-matched control mice. Plasma glucose and insulin concentrations were significantly lower in the IGF-II transgenic compared with both control groups. Despite decreased plasma glucose concentration, basal hepatic glucose production (HGP) and glucose clearance were increased. During the insulin clamp studies in IGF-II transgenic mice compared with control mice (a) the rates of glucose infusion and glucose uptake were increased by ~65 and ~55%, respectively; (b) glycolysis was increased by ~12% while glycogen synthesis was ~2-fold higher; (c) while the suppression of plasma free fatty acid was similar, the increment in plasma lactate concentration was significantly higher; (d) although HGP was similarly inhibited by insulin, phosphoenolpyruvate gluconeogenesis was enhanced and accounted for a larger portion of HGP (64% versus ~40% in control mice). Our data suggest that the persistence of circulating IGF-II in adult mice to levels commonly observed in adult humans (50-70 nM) causes a marked improvement in peripheral (skeletal muscle) insulin action, which is not due to changes in body composition. These results suggest that circulating IGF- II may exert a regulatory role on insulin sensitivity and body composition in humans.

Original languageEnglish (US)
Pages (from-to)203-208
Number of pages6
JournalJournal of Biological Chemistry
Issue number1
StatePublished - Jan 5 1996
Externally publishedYes


ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this